Baxter
BAX
#905
Rank
$20.54 B
Marketcap
$40.33
Share price
-4.25%
Change (1 day)
-6.60%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Baxter (BAX) - Total debt

Total debt on the balance sheet as of December 2023 : $14.36 B

According to Baxter's latest financial reports the company's total debt is $14.36 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Baxter - Total debt on balance sheet (from 2001 to 2023)

Total debt by year

Year Total debt Change
2023-12-31$14.36 B-16.5%
2022-12-31$17.20 B-6.05%
2021-12-31$18.31 B169.11%
2020-12-31$6.80 B14.14%
2019-12-31$5.96 B71.05%
2018-12-31$3.48 B-0.77%
2017-12-31$3.51 B26.24%
2016-12-31$2.78 B-57.25%
2015-12-31$6.50 B-27.93%
2014-12-31$9.02 B-1.49%
2013-12-31$9.16 B54.57%
2012-12-31$5.93 B14.15%
2011-12-31$5.19 B18.42%
2010-12-31$4.38 B5.69%
2009-12-31$4.15 B10.52%
2008-12-31$3.75 B21.59%
2007-12-31$3.08 B10.28%
2006-12-31$2.80 B-16.09%
2005-12-31$3.33 B-22.26%
2004-12-31$4.29 B-6.12%
2003-12-31$4.57 B-1.57%
2002-12-31$4.64 B72.94%
2001-12-31$2.68 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
$25.18 B 75.31%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$34.91 B 143.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$16.11 B 12.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.49 B-33.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.99 B-9.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.72 B-67.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.70 B-88.14%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.49 B-89.56%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.31 B-83.85%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA